SITC Archive Library

SITC 28th Annual Meeting 

03-01-2018 15:11

The Society for Immunotherapy of Cancer (SITC) 28th Annual Meeting
November 8-10, 2013
Gaylord National Hotel & Convention Center
National Harbor, MD

Program Organizers
Paolo Antonio Ascierto, MD - Instituto Nazionale Tumori-Fondazione ‘G. Pascale’
David H. Munn, MD - Georgia Regents University
A. Karolina Palucka, MD, PhD - Baylor Institute for Immunology Research
Paul M. Sondel, MD, PhD - University of Wisconsin

Program Summary
The SITC 28th Annual Meeting provided a multidisciplinary educational and interactive environment focused on improving the outcome for current and future patients with cancer by incorporating strategies based on basic and applied cancer immunotherapy. The meeting consisted of cutting-edge research presentations by experts in the field, both oral and poster abstract presentations and ample opportunity for structured and informal discussions, including important networking opportunities. In addition, the meeting included updates on major national and international initiatives coming from academia, government and industry, as well as important society projects.

Target Audience
The target audience for this program was basic and clinical investigators from academic institutions, industry and regulatory agencies, including clinicians, basic and translational researchers, graduate students, post-doctoral fellows, and allied health professionals involved in cancer research as well as pharmacists and payers, that wish to learn more about cancer immunology and immunotherapy, and its incorporation into current (and future) effective cancer treatment.

Presentations and video recordings are available based on permission from presenters.


#ClinicalTrials #Immunoscore #ColorectalCancer #HeadandNeckCancers #Neuroblastoma #ProstateCancer #PresentationSlides #AnnualMeeting #ImmuneCheckpointInhibitors #TherapeuticAntibodies #Vaccines #AlliedHealth #Clinician #Industry #Oncologist #Researcher #2013 #BreastCancers
#ColonCancer #Melanoma #Non-SmallCellLungCancer #GastrointestinalCancers #OvarianCancer #RenalCellCarcinoma
#AdoptiveCellTherapy #CombinationTherapy #Ipilimumab #Nivolumab

Statistics
0 Favorited
48 Views
22 Files
0 Shares
55 Downloads
Attachment(s)
pdf file
Update Session - Cancer Immunotherapy Trials Network   813 KB   1 version
Uploaded - 03-01-2018
Meeting: SITC 28th Annual Meeting; Presentation: Update Session - Cancer Immunotherapy Trials Network; Presenter: Martin A. Cheever, MD - Fred Hutchinson Cancer Research Center; Date: Friday, November 8, 2013
pdf file
Update Session - Immunoscore   4.08 MB   1 version
Uploaded - 03-01-2018
Meeting: SITC 28th Annual Meeting; Presentation: Update Session - Immunoscore; Presenter: Bernard A. Fox, MD - Earle A. Chiles Research Institute; Date: Friday, November 8, 2013
pdf file
Cancer, Inflammation, and Microbiota   8.95 MB   1 version
Uploaded - 03-01-2018
Meeting: SITC 28th Annual Meeting; Presentation: Keynote: Cancer, Inflammation, and Microbiota; Presenter: Giorgio Trinchieri, MD - National Cancer Institute; Date: Friday, November 8, 2013
pdf file
Ambivalent Effects of 5-Flouorouracil on Anticancer Immun...   1.53 MB   1 version
Uploaded - 03-01-2018
Meeting: SITC 28th Annual Meeting; Presentation: Ambivalent Effects of 5-Flouorouracil on Anticancer Immune Responses; Presenter: Lionel Apetoh, PhD - INSERM; Date: Friday, November 8, 2013
pdf file
Modulating Tumor Microenvironment Responses to Genotoxic ...   14.79 MB   1 version
Uploaded - 03-01-2018
Meeting: SITC 28th Annual Meeting; Presentation: Modulating Tumor Microenvironment Responses to Genotoxic Cancer Therapy; Presenter: Peter S. Nelson, MD - Fred Hutchinson Cancer Research Center; Date: Friday, November 8, 2013
pdf file
Listeria monocytogenes (Lm)-LLO Immunotherapies Reduce th...   251 KB   1 version
Uploaded - 03-01-2018
Meeting: SITC 28th Annual Meeting; Presentation: Listeria monocytogenes (Lm)-LLO Immunotherapies Reduce the Immunosuppressive Activity of Myeloid-derived Suppressor Cells and Regulatory T Cells in the Tumor Microenvironment; Presenter: Anu Wallecha, PhD - Advaxis, Inc.; Date: Friday, November 8, 2013
pdf file
Cross-talks of Tumor and Myeloid Cells Regulate the Thera...   2.78 MB   1 version
Uploaded - 03-01-2018
Meeting: SITC 28th Annual Meeting; Presentation: Cross-talks of Tumor and Myeloid Cells Regulate the Therapeutic Responses to Chemotherapy by Modulating Innate Immune Responses; Presenter: Masahisa Jinushi, MD, PhD - Hokkaido University; Date: Friday, November 8, 2013
pdf file
Update Session - U.S. Food and Drug Administration   65 KB   1 version
Uploaded - 03-01-2018
Meeting: SITC 28th Annual Meeting; Presentation: Update Session - U.S. Food and Drug Administration; Presenter: Raj K. Puri, MD, PhD - U.S. Food and Drug Administration, CBER; Date: Friday, November 8, 2013
pdf file
In Vivo ADCC to Treat Neuroblastoma   2.16 MB   1 version
Uploaded - 03-01-2018
Meeting: SITC 28th Annual Meeting; Presentation: In Vivo ADCC to Treat Neuroblastoma; Presenter: Paul M. Sondel, Md, PhD - University of Wisconsin; Date: Friday, November 8, 2013
pdf file
In Vivo Persistence of Adoptively Transferred TCR Gene-tr...   4.77 MB   1 version
Uploaded - 03-01-2018
Meeting: SITC 28th Annual Meeting; Presentation: In Vivo Persistence of Adoptively Transferred TCR Gene-transduced Lymphocytes with Anti-Tumor Reactivity in Patients with MAGE-A4 Expressing Esophageal Cancer; Presenter: Hiroaki Ikeda, MD, PhD - Mie University Graduate School of Medicine; Date: Friday, November 8, 2013
pdf file
Intratumoral Characteristics of Tumor and Immune Cells at...   1.81 MB   1 version
Uploaded - 03-01-2018
Meeting: SITC 28th Annual Meeting; Presentation: Intratumoral Characteristics of Tumor and Immune Cells at Baseline and On-Treatment Correlated with Clinical Responses to MPDL3280A, an Engineered Antibody Against PD-L1; Presenter: Holbrook Kohrt, MD, PhD - Stanford Cancer Institute; Date: Friday, November 8, 2013
pdf file
Update Session - National Cancer Institute   925 KB   1 version
Uploaded - 03-01-2018
Meeting: SITC 28th Annual Meeting; Presentation: Update Session - National Cancer Institute; Presenter: William D. Merritt, PhD - National Cancer Institute; Date: Saturday November 9, 2013
pdf file
Modified STING-Activating Cyclic Dinucleotide Derivatives...   2.25 MB   1 version
Uploaded - 03-01-2018
Meeting: SITC 28th Annual Meeting; Presentation: Modified STING-Activating Cyclic Dinucleotide Derivatives Significantly Enhance the Anti-Tumor Activity of Therapeutic Vaccines; Presenter: Thomas W. Dubensky, Jr., PhD - Aduro BioTech, Inc.; Date: Saturday November 9, 2013
pdf file
kg   944 KB   1 version
Uploaded - 03-01-2018
Meeting: SITC 28th Annual Meeting; Presentation: The Abscopal Effect: Efficacy of Radiotherapy in Patients on Progression After Treatment with Ipilimumab 3 mg/kg; Presenter: Antonio M. Grimaldi, MD - Istituto Nazionale Tumori Foundazione 'G. Pascale; Date: Saturday November 9, 2013
pdf file
Transgenic Expression of Notch-1 Intracellular Active Dom...   3.24 MB   1 version
Uploaded - 03-01-2018
Meeting: SITC 28th Annual Meeting; Presentation: Transgenic Expression of Notch-1 Intracellular Active Domain (N1IC) in T Cells - A Potential Therapy to Overcome Suppression Induced by Tumors; Presenter: Paulo C. Rodriguez, PhD - LSUHSC - Stanley S. Scott Cancer Center; Date: Saturday November 9, 2013
pdf file
TLR2-6 Agonists and IFN-gamma Synergize to Induce Melanom...   4.47 MB   1 version
Uploaded - 03-01-2018
Meeting: SITC 28th Annual Meeting; Presentation: TLR2-6 Agonists and IFN-gamma Synergize to Induce Melanoma Cells to Produce T-cell Recruiting Chemokines; Presenter: Ileana S. Mauldin, PhD - University of Virginia; Date: Saturday November 9, 2013
pdf file
Uncovering a Novel Function of BTLA on Tumor-Infiltrating...   2.46 MB   1 version
Uploaded - 03-01-2018
Meeting: SITC 28th Annual Meeting; Presentation: Uncovering a Novel Function of BTLA on Tumor-Infiltrating CD8+ T Cells; Presenter: Cara Haymaker, PhD - MD Anderson Cancer Center; Date: Saturday November 9, 2013
pdf file
III Melanoma   3.70 MB   1 version
Uploaded - 03-01-2018
Meeting: SITC 28th Annual Meeting; Presentation: Dissection of Genomic Networks for Immunosurveillance in Resectable Stage II/III Melanoma; Presenter: Yvonne Saenger, MD - Mount Sinai School of Medicine; Date: Saturday November 9, 2013
pdf file
Combinations of Anti-cancer Immune Therapies Built on Che...   1.76 MB   1 version
Uploaded - 03-02-2018
Meeting: SITC 28th Annual Meeting; Presentation: Combinations of Anti-cancer Immune Therapies Built on Checkpoint Inhibition; Presenter: Mario Sznol, MD - Yale University School of Medicine; Date: Sunday November 10, 2013
pdf file
Therapeutic Activity of a Combination of Immunostimulator...   1.55 MB   1 version
Uploaded - 03-02-2018
Meeting: SITC 28th Annual Meeting; Presentation: Therapeutic Activity of a Combination of Immunostimulatory Monoclonal Antibodies (anti-B7-H1, CD137 and OX40) on a C-myc-driven Spontaneous Transgenic Model of Hepatocellular Carcinoma; Presenter: Aizea Morales-Kastresana - Center for Applied Medical research (CIMA); Date: Sunday November 10, 2013
pdf file
Localized Oncolytic Virotherapy Inflames Distant Tumors a...   2.24 MB   1 version
Uploaded - 03-02-2018
Meeting: SITC 28th Annual Meeting; Presentation: Localized Oncolytic Virotherapy Inflames Distant Tumors and Synergizes with Immune Checkpoint Blockade Leading to Systemic Tumor Rejection; Presenter: Dmitriy Zamarin, MD, PhD - Memorial Sloan-Kettering Cancer Center; Date: Sunday November 10, 2013
pdf file
Targeting Tumor to Generate Systemic Immunity   706 KB   1 version
Uploaded - 03-02-2018
Meeting: SITC 28th Annual Meeting; Presentation: Targeting Tumor to Generate Systemic Immunity; Presenter: Yang-Xin Fu, Md, PhD - University of Chicago; Date: Sunday November 10, 2013